Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Coronary risk assessment by point-based vs. equation-based Framingham models: significant implications for clinical care.

Gordon WJ, Polansky JM, Boscardin WJ, Fung KZ, Steinman MA.

J Gen Intern Med. 2010 Nov;25(11):1145-51. doi: 10.1007/s11606-010-1454-2.

2.

Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.

Foster MC, Rawlings AM, Marrett E, Neff D, Grams ME, Kasiske BL, Willis K, Inker LA, Coresh J, Selvin E.

Am J Kidney Dis. 2014 May;63(5):753-60. doi: 10.1053/j.ajkd.2013.11.014.

5.

Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.

Tóth PP, Potter D, Ming EE.

J Clin Lipidol. 2012 Jul-Aug;6(4):325-30. doi: 10.1016/j.jacl.2012.05.002.

PMID:
22836069
6.

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L.

Ann Intern Med. 2009 Feb 17;150(4):243-54.

PMID:
19221376
7.

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey.

Zhang B, Menzin J, Friedman M, Korn JR, Burge RT.

Curr Med Res Opin. 2008 Sep;24(9):2711-7. doi: 10.1185/03007990802363198 .

PMID:
18701005
8.

Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).

Guttormsen BN, Stein JH, McBride PE, Cullen MW, Gangnon R, Keevil JG.

Am J Cardiol. 2007 Oct 1;100(7):1130-3.

PMID:
17884376
9.

Relative importance of borderline and elevated levels of coronary heart disease risk factors.

Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy D, D'Agostino RB.

Ann Intern Med. 2005 Mar 15;142(6):393-402. Erratum in: Ann Intern Med. 2005 Apr 19;142(8):681.

PMID:
15767617
10.

Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.

Riddell T, Wells S, Jackson R, Lee AW, Crengle S, Bramley D, Ameratunga S, Pylypchuk R, Broad J, Marshall R, Kerr A.

N Z Med J. 2010 Feb 19;123(1309):50-61.

PMID:
20186242
11.
12.

Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.

Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D.

JAMA. 2004 Jun 2;291(21):2591-9.

PMID:
15173150
13.

Adding multiple risk factors improves Framingham coronary heart disease risk scores.

Hu G, Root M, Duncan AW.

Vasc Health Risk Manag. 2014 Sep 5;10:557-62. doi: 10.2147/VHRM.S69672.

14.

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.

PMID:
17357251
15.

Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.

Huse DM, Song X, Ozminkowski RJ, Maguire J, Williams SA, Borok GM, McDonough K.

Clin Ther. 2006 Sep;28(9):1425-42.

PMID:
17062315
16.

Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):109-14.

17.

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, et al.

JAMA. 1993 Jun 16;269(23):3009-14.

PMID:
8501843
18.

Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States.

Sait AS, Kuo A, Bettencourt R, Bergstrom J, Allison M, von Drygalski A.

Haemophilia. 2014 Nov;20(6):763-70. doi: 10.1111/hae.12472.

PMID:
24893625
19.

The population effects of the global cardiovascular risk model in United States adults: findings from the National Health and Nutrition Surveys, 2005-2006.

Tattersall MC, Karmali KN, Gangnon RE, Keevil JG.

J Clin Lipidol. 2011 May-Jun;5(3):166-72. doi: 10.1016/j.jacl.2011.02.007.

20.

Cholesterol: precursor to many lipid disorders.

Jones PH.

Am J Manag Care. 2001 Aug;7(9 Suppl):S289-98. Review.

Items per page

Supplemental Content

Support Center